Special Issue
Dipeptidyl peptidase IV and related molecules in health and disease
Submission Deadline: 31 December 2019
Articles: 24
Special Issue Editor
Guest Editor
Jonathan S. Duke-Cohan
Ph.D., Dana-Farber Cancer Institute, Medical Oncology, JF517, 450 Brookline Avenue, Boston MA 02215
Expertise: 70 publications, 7 grants, Editor of Frontiers in Bioscience
Aleksi Sedo
M.D., Ph.D., Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology of the First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic
Expertise: >50 publications, grants, Editor of Frontiers in Bioscience
Manuscript Submission Information

Manuscripts should be submitted online at https://jour.ipublishment.com/bri by registering and logging into this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page.

Please visit the Instructions for Authors page before submitting a manuscript. Submitted papers should be well formatted and written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see

here.

Keywords
Blood and Bone Marrow, Cancer, Cardiovascular System, Cell Biology, Development, Endocrine System, Genes and Genetics, Immune System, Inflammatory Responses, Nervous System, Nutrition, Molecular Biology, Signaling, Skin and Integument, Therapeutics
Share This Special Issue
Published Papers (24 papers)
Open Access
Review

Fibroblast activation protein in liver fibrosis

Angelina J. Lay, Hui E. Zhang, Geoffrey W. McCaughan, Mark D. Gorrell
Frontiers in Bioscience-Landmark Volume 24 Issue 1, pp.1-17
DOI: 10.2741/4706 Published: 01 January 2019
Open Access
Review

GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond

Barbora Vorlova, Tomas Knedlik, Jan Tykvart, Jan Konvalinka
Frontiers in Bioscience-Landmark Volume 24 Issue 4, pp.648-687
DOI: 10.2741/4742 Published: 01 March 2019
Open Access
Review

Anti-diabetic treatment leads to changes in gut microbiome

Eleni Xourgia, Athanasia Papazafiropoulou, Nikolaos Papanas, Andreas Melidonis
Frontiers in Bioscience-Landmark Volume 24 Issue 4, pp.688-699
DOI: 10.2741/4743 Published: 01 March 2019
Open Access
Article
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor
Mario Gonzalez-Gronow, Steven Kaczowka, Govind Gawdi, Salvatore V Pizzo
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1610-1618
DOI: 10.2741/2785 Published: 01 January 2008
Open Access
Article
The role of CD26/dipeptidyl peptidase IV in cancer
Pamela A Havre, Masako Abe, Yasuyo Urasaki, Kei Ohnuma, Chikao Morimoto, Nam H Dang
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1634-1645
DOI: 10.2741/2787 Published: 01 January 2008
Open Access
Article
Dipeptidyl peptidase IV inhibitors and diabetes therapy
Christopher H S McIntosh
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1753-1773
DOI: 10.2741/2797 Published: 01 January 2008
Open Access
Review

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target

Kei Ohnuma, Ryo Hatano, Eriko Komiya, Haruna Otsuka, Takumi Itoh, Noriaki Iwao, Yutaro Kaneko, Taketo Yamada, Nam H. Dang, Chikao Morimoto
Frontiers in Bioscience-Landmark Volume 23 Issue 9, pp.1754-1779
DOI: 10.2741/4671 Published: 01 June 2018
Open Access
Article
SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26
Martin Hildebrandt, Richard Schabath
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1774-1779
DOI: 10.2741/2798 Published: 01 January 2008
Open Access
Article
DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
Carolyn F Deacon, Richard D Carr, Jens J Holst
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1780-1794
DOI: 10.2741/2799 Published: 01 January 2008
Open Access
Article
CD26 inhibition and hematopoiesis: a novel approach to enhance transplantation
Timothy B Campbell, Hal E Broxmeyer
Frontiers in Bioscience-Landmark Volume 13 Issue 5, pp.1795-1805
DOI: 10.2741/2800 Published: 01 January 2008
Open Access
Review

Targeting fibroblast activation protein in cancer – Prospects and caveats

Petr Busek, Rosana Mateu, Michal Zubal, Lenka Kotackova, Aleksi Sedo
Frontiers in Bioscience-Landmark Volume 23 Issue 10, pp.1933-1968
DOI: 10.2741/4682 Published: 01 June 2018
Open Access
Article
Role of CD26/dipeptidyl peptidase IV in human T cell activation and function
Kei Ohnuma, Nozomu Takahashi, Tadanori Yamochi, Osamu Hosono, Nam H Dang, Chikao Morimoto
Frontiers in Bioscience-Landmark Volume 13 Issue 6, pp.2299-2310
DOI: 10.2741/2844 Published: 01 January 2008
Open Access
Article
Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors--good or evil?
Petr Busek, Jarmila Stremenova, Aleksi Sedo
Frontiers in Bioscience-Landmark Volume 13 Issue 6, pp.2319-2326
DOI: 10.2741/2846 Published: 01 January 2008
Open Access
Article
Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis
Giulio Ghersi
Frontiers in Bioscience-Landmark Volume 13 Issue 6, pp.2335-2355
DOI: 10.2741/2848 Published: 01 January 2008
Open Access
Article
DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
Dirk Reinhold, Ute Bank, Michael Täger, Siegfried Ansorge, Sabine Wrenger, Anja Thielitz, Uwe Lendeckel, Jürgen Faust, Klaus Neubert, Stefan Brocke
Frontiers in Bioscience-Landmark Volume 13 Issue 6, pp.2356-2363
DOI: 10.2741/2849 Published: 01 January 2008
Open Access
Article
The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases
Anja Thielitz, Siegfried Ansorge, Ute Bank, Michael Tager, Sabine Wrenger, Harald Gollnick, Dirk Reinhold
Frontiers in Bioscience-Landmark Volume 13 Issue 6, pp.2364-2375
DOI: 10.2741/2850 Published: 01 January 2008
Open Access
Article
Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation
Carolyn McGuinness, Umadevi V Wesley
Frontiers in Bioscience-Landmark Volume 13 Issue 7, pp.2435-2443
DOI: 10.2741/2856 Published: 01 January 2008
Open Access
Article
Fibroblast activation protein and chronic liver disease
Xin Maggie Wang, Tsun-Wen Yao, Naveed A Nadvi, Brenna Osborne, Geoffrey W McCaughan, Mark D Gorrell
Frontiers in Bioscience-Landmark Volume 13 Issue 8, pp.3168-3180
DOI: 10.2741/2918 Published: 01 January 2008
Open Access
Article
Non-substrate peptides influencing dipeptidyl peptidase IV/CD26 activity and immune cell function
Sabine Wrenger, Jurgen Faust, Carmen Mrestani-Klaus, Wolfgang Brandt, Anja Thielitz, Klaus Neubert, Dirk Reinhold
Frontiers in Bioscience-Landmark Volume 13 Issue 9, pp.3194-3201
DOI: 10.2741/2920 Published: 01 May 2008
Open Access
Article
Purification and characterization of dipeptidyl peptidase IV-like enzymes from bovine testes
Veronique Dubois, Anne-Marie Lambeir, Pieter Van der Veken, Koen Augustyns, John Creemers, Xin Chen, Simon Scharpé, Ingrid De Meester
Frontiers in Bioscience-Landmark Volume 13 Issue 9, pp.3558-3568
DOI: 10.2741/2949 Published: 01 May 2008
Open Access
Article
Dipeptidyl peptidase 8 and 9--guilty by association?
Melissa R Pitman, Melanie L Sulda, Bryone Kuss, Catherine A Abbott
Frontiers in Bioscience-Landmark Volume 14 Issue 10, pp.3619-3633
DOI: 10.2741/3476 Published: 01 January 2009
Open Access
Article
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Peter R Flatt, Clifford J Bailey, Brian D Green
Frontiers in Bioscience-Landmark Volume 13 Issue 10, pp.3648-3660
DOI: 10.2741/2956 Published: 01 May 2008
Open Access
Article
Inflammatory bowel diseases: multiple benefits from therapy with dipeptidyl- and alanyl-aminopeptidase inhibitors
Ute Bank, Ulrich R M Bohr, Dirk Reinhold, Uwe Lendeckel, Siegfried Ansorge, Peter Malfertheiner, Michael Tager
Frontiers in Bioscience-Landmark Volume 13 Issue 10, pp.3699-3713
DOI: 10.2741/2960 Published: 01 May 2008
Open Access
Article
Inhibiting dipeptidyl peptidase activity partially ameliorates colitis in mice
Roger Yazbeck, Gordon S Howarth, Mark S Geier, Hans-Ulrich Demuth, Catherine A Abbott
Frontiers in Bioscience-Landmark Volume 13 Issue 18, pp.6850-6858
DOI: 10.2741/3193 Published: 01 May 2008